- PIRENOXINE SODIUM
-
-
2026-06-30
- CAS:51410-30-1
- Min. Order: 1KG
- Purity: 98.0%
- Supply Ability: 10000KGS
|
| | 1-Hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylic acid monosodium salt Basic information |
| | 1-Hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylic acid monosodium salt Chemical Properties |
| InChI | InChI=1S/C16H8N2O5.Na/c19-9-5-8(16(21)22)18-14-10(20)6-12-15(13(9)14)17-7-3-1-2-4-11(7)23-12;/h1-6H,(H,18,19)(H,21,22);/q;+1/p-1 | | InChIKey | HDQXPMXHXZNPKE-UHFFFAOYSA-M | | SMILES | [Na+].C12=C(O)C=C(C([O-])=O)N=C1C(=O)C=C1C2=NC2=C(C=CC=C2)O1 |
| Toxicity | LD50 in mice (mg/kg): >10000 orally; >5000 s.c.; 2120-2250 i.p. LD50 in rats (mg/kg) i.p.: 2400 (males); 1460 (females) (Ikemoto) |
| | 1-Hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylic acid monosodium salt Usage And Synthesis |
| Uses | Pirenoxine is a medication used in the possible treatment and prevention of cataracts. |
| | 1-Hydroxy-5-oxo-5H-pyrido[3,2-a]phenoxazine-3-carboxylic acid monosodium salt Preparation Products And Raw materials |
|